Skip to main content

Mar Tintore Subirana

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC).

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Clinical neuroimmunology
General Hospital
Director
Multiple Sclerosis Centre of Catalonia

Mar Tintore Subirana

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Clinical neuroimmunology
General Hospital
Director
Multiple Sclerosis Centre of Catalonia

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC).

I have developed in particular the study of prognostic factors, multiple sclerosis of the child and adolescent, as well as family planning in women with multiple sclerosis. I am currently a member of the Advisory Ethics Committee (CEA) of the Vall d'Hebron University Hospital.

I have published more than 369 articles in national and international journals and am a regular reviewer of indexed journals both national and international. My factor H is currently 60 and until April 2026 my work has received 26,854 citations.

Projects

Estudio de genes candidatos en regiones de susceptibilidad para la esclerosis múltiple

IP: Manuel Comabella Lopez
Collaborators: Mar Tintore Subirana
Funding agency: Instituto de Salud Carlos III
Funding: 131890
Reference: PI061906
Duration: 01/01/2007 - 30/06/2010

Análisis proteómico en líquido cefaloraquídeo y suero de pacientes con síndromes clínicos aislados sugestivos de esclerosis múltiple

IP: Mar Tintore Subirana
Collaborators: Manuel Comabella Lopez
Funding agency: Instituto de Salud Carlos III
Funding: 141015
Reference: PI050588
Duration: 01/01/2006 - 31/01/2009

Estudio de la función de las células dentríticas (CD) en la esclerosis múltiple (EM). Diferencias entre las distintas formas clínicas de la enfermedad.

IP: Mar Tintore Subirana
Collaborators: Jordi Rio Izquierdo, Manuel Comabella Lopez
Funding agency: Instituto de Salud Carlos III
Funding: 31740
Reference: PI020158
Duration: 06/11/2002 - 06/11/2005

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Mireia Armengol Alsina

Mireia Armengol Alsina

Main researcher
Maternal and Fetal Medicine
Read more
Silvia Alcaraz Casanovas

Silvia Alcaraz Casanovas

Research assistant
Multidisciplinary Nursing Research Group
Read more
Eloy Rodríguez Muñoz

Eloy Rodríguez Muñoz

Research assistant
Donation and transplantation of organs, tissues and cells
Read more
Pedro Pablo Jordán Marchite

Pedro Pablo Jordán Marchite

Predoctoral researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.